Antibiotic susceptibility of Helicobacter pylori isolates in Dakar, Senegal

Journal of Infection in Developing Countries

Volumn 3, Issue 2, 2009, Pages 137-140

  Seck, Abdoulaye ^a   Mbengue, Mouhamadou ^b   Gassama Sow, Amy ^a   Diouf, Lamine ^b   Ka, Mouhamadou Mourtalla ^b   Boye, Cheikh Saad Bouh ^b  

^a INSTITUT PASTEUR DE DAKAR   (Senegal)

^b Department of Obstetrics   (Senegal)

Author keywords

Antimicrobial susceptibility; Helicobacter pylori; Senegal

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; CIPROFLOXACIN; METRONIDAZOLE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; DUODENUM ULCER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; SENEGAL; STOMACH ULCER;

ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; DUODENAL ULCER; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; SENEGAL; STOMACH ULCER;

EID: 73349093132     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.512     Document Type: Article

References (21)

1. Blaser MJ (1997) Ecology of Helicobacter pylori in the human stomach. J Clin Invest 100:759-762.
2. Holocombe C, Ouattara BA, Elridge J, Jones DM (1992) Helicobacter pylori, the most common bacterial infection in AFRICA: a random serological study. Am J Gastroenterol 87: 28-30.
3. Mbaye PS, Fall F, Michel G, Klotz F (1998) Etude de l'éradication d'Helicobacter pylori chez des malades sénégalais atteints d'ulcère duodénal. Acta Endoscopica 28 Suppl 3: 285.
4. Graham DY and Go MF (1993) Helicobacter pylori: current status. Gastroenterology 105: 279-282.
5. Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ Jr, Saeed ZA, Malaty HM (1992) Effect of treatment of infection Helicobacter pylori on the long-term recurrence of gastric or duodenal ulcer: a randomized controlled study. Ann Int Med 116: 705-708.
6. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease (1994) NIH, Consensus, and Conference: Helicobacter pylori in peptic ulcer disease. JAMA 272:65-69.
7. Glupczynski Y, Burette A, De Koster E, Nyst JF, Deltenre M, Cadranel S et al. (1990) Metronidazole resistance in Helicobacter pylori. Lancet 335: 967-1077.
8. Megraud F, Lehn N, Lind T, Bayerdörffer E, O'Morain C, Spiller R et al. (1999) Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother 43: 2747-2752.
9. Boyanova L, Koumanova R, Gergova G et al. (2002) Prevalence of resistant Helicobacter pylori isolates in Bulgarian children. J Med Microbial 51: 786-790.
10. Kalach N, Serhal L, Asmar E, Campeotto F, Bergeret M, Dehecq E, Spyckerelle C, Charkaluk ML, Decoster A, Dupont C, Raymond J (2007) Helicobacter pylori primary resistant strains over 11 years in French children. Diagn Microbiol Infect Dis 59:217-222.
11. Albert JM, Al-Mekhaizeem K, Neil L, Dhar R, Dhar PM, Al-Ali M, Al-Abkal HM, Haridas S (2006) High prevalence and level of resistance to metronidazole, but lack of resistance to other antimicrobials in Helicobacter pylori, isolated from a multiracial population in Kuwait. Aliment Pharmacol Ther 24:1359-1366.
12. Megraud F (2004) H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53:1374-1384.
13. Duck WM, Sobel J, Pruckler JM, Song Q, Swerdlow D, Friedman C, Sulka A, Swaminathan B, Taylor T, Hoekstra M, Griffin P, Smoot D, Peek R, Metz DC, Bloom PB, Goldschmidt S, Parsonnet J, Triadafilopoulos G, Perez-Perez GI, Vakil N, Ernst P, Czinn S, Dunne D, Gold BD (2004) Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States. Emerg Infect Dis 10:1088-1094.
14. Kim JM, Kim JS, Kim N, Kim SG, Jung HC, Song IS (2006) Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients. Int J Antimicrob Agents 28:6-13.
15. Kumala W and Rani A (2006) Patterns of Helicobacter pylori isolate resistance to fluoroquinolones, amoxicillin, clarithromycin and metronidazole. Southeast Asian J Trop Med Public Health 37:970-974.
16. Thyagarajan SP, Ray P, Das BK, Ayyagari A, Khan AA, Dharmalingam S, Rao UA, Rajasambandam P, Ramathilagam B, Bhasin D, Sharma MP, Naik SR, Habibullah CM (2003) Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: Multicentric study. J Gastroenterol Hepatol 18:1373-1378.
17. Godoy APO, Ribeiro ML, Benvengo YH, Vitiello L, Miranda Mde C, Mendonça S, Pedrazzoli J Jr (2003) Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates. BMC Gastroenterol 11: 3:20.
18. Abordin OA, Abdu AR, Odetoyin BW, Okeke IN, Lawal OO, Ndububa DA, Agbakwuru AE and Lamikanra A (2007) Antibiotic resistance of Helicobacter pylori from patients in Ile-Ife, South-west, Nigeria. African Health Science 7: 143-147.
19. Glocker E, Stueger HP, Kist M (2007) Quinolone resistance in Helicobacter pylori isolates in Germany. Antimicrob Agents Chemother 51:346-349.
20. Sherif M, Mohran Z, Fathy H, Rockabrand DM, Rozmajzl PJ, Frenck RW (2004) Universal high-level primary metronidazole resistance in Helicobacter pylori isolated from children in Egypt. J Clin Microbiol 42 Suppl 10:4832-4834.
21. Glupczynski Y, Broutet N, Cantagrel A, Andersen LP, Alarcon T, López-Brea M, Megraud F (2002) Comparison of the E test and agar dilution method for antimicrobial susceptibility testing of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 21:549-552.